Barden Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Barden Capital Management's LLY Position: Q3 2026 in Review
Barden Capital Management increased its Eli Lilly (LLY) stake by 0.2% in Q3 2026, buying an estimated $4.72K and bringing the position to 2,034 shares worth $2.35M. The position accounts for 2.14% of the portfolio, ranked #14.
Barden Capital Management first reported a position in LLY in Q3 2022 and has held it in 17 quarters since. The position peaked at $2.96M in Q2 2024. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Barden Capital Management held 2,034 shares of Eli Lilly worth $2.35M as of Q3 2026.
- Barden Capital Management bought 4 Eli Lilly shares in Q3 2026, an estimated $4.72K.
- Eli Lilly made up 2.14% of Barden Capital Management's portfolio in Q3 2026, its #14 holding.
- Barden Capital Management first reported a position in Eli Lilly in Q3 2022 and has held it in 17 quarters since.
- Barden Capital Management's Eli Lilly position peaked at $2.96M in Q2 2024.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Barden Capital Management's 13F filing for Q3 2026, filed 9 Oct 2026.